Nuclear Medicine Content
The Mount Sinai Hospital is ranked No. 1 in Geriatrics in the nation by U.S. News & World Report for the third consecutive year.
The Urology Residency Program of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai provides residents the opportunity to train in all aspects of the medical and surgical evaluation and treatment ...
Mount Sinai’s Department of Urology continues to make strides in training a new generation in the necessary clinical, surgical, and decision-making skills to deliver outstanding care to patients in an area undergoing rapid change.
Mount Sinai has established itself as a leader in sex reassignment surgery (SRS) and reconstruction of genitalia, thanks in part to the pioneering work of Miroslav Djordjevic, MD, PhD, a leading authority on surgery for transgender individuals.
By continuing to perfect the miniaturization of percutaneous nephrolithotomy (PCNL), surgeons at the Mount Sinai Department of Urology are significantly improving outcomes for patients with larger kidney stones.
Advances in imaging, biomarkers, and genetic testing continue to benefit patients who present with prostate and bladder cancers.
Two physician-researchers in the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai have been recognized for making unique contributions to urology research...
Mount Sinai has developed a protocol that eliminates opioids from postoperative pain management with exceptional results.
Although there is considerable interest in using immunotherapy to combat and control prostate cancer, there has been little progress made in harnessing the potential of this approach.
As the family of technologies for treating benign prostatic hyperplasia (BPH) continues to grow, the key to successful outcomes for male patients may well rest on a rather simple tenet: better diagnostic acumen.
For years, rare renal cell carcinomas (RCCs), such as papillary RCC, have been understudied because their incidences are too low to support clinical trials.
An innovative effort by the Milton and Carroll Petrie Department of Urology and Ash Tewari, MBBS, MCh, FRCS (Hon.), Professor and System Chair, to improve early detection of prostate cancer among at-risk populations in New York City...
Mount Sinai’s Scott Scheinin, MD, and Harish Seethamraju, MD, are establishing the End-Stage Lung Disease and Transplant Program as a leader in treating complex cases.
A first-of-its-kind study led by a Mount Sinai researcher suggests that even a brief withdrawal of continuous positive airway pressure therapy for sleep apnea might increase one’s risk of developing Alzheimer’s disease.